In a striking and hopeful vision of tomorrow, Demis Hassabis, the visionary co-founder and CEO of a leading AI research lab, has stirred the global conversation by predicting that artificial intelligence could cure all diseases within the next ten years.
His awe-inspiring outlook received an unexpected but powerful endorsement from Aravind Srinivas, the CEO of a competing artificial intelligence platform. Despite being rivals in the artificial intelligence race, Srinivas didn’t hold back, calling Hassabis a “genius” and declaring, “he should be given all the resources in the world to make this happen.”
This future-facing conversation unfolded during a recent interview aired on a major primetime segment, where Hassabis unpacked the revolutionary potential of artificial intelligence in healthcare.
“So on average, it takes, you know, ten years and billions of dollars to design just one drug,” Hassabis shared. “We can maybe reduce that down from years to maybe months or maybe even weeks. Which sounds incredible today, but that’s also what people used to think about protein structures. And it would revolutionise human health, and I think one day maybe we can cure all diseases with the help of AI.”
When asked the big question, could Artificial Intelligence end all diseases? Hassabis didn’t shy away from optimism.
“I think that’s within reach. Maybe within the next decade or so, I don’t see why not,” he confidently stated.
Reacting to the interview, Aravind Srinivas took to social media to publicly support Hassabis, writing, “Demis is a genius and he should be given all the resources in the world to make this happen.” A rare moment of admiration from one innovator to another, especially as their technologies go head-to-head in redefining how the world interacts with information.
Perplexity AI, Srinivas’s startup, is known for its advanced AI-driven search engine and is preparing to launch an “agentic browser”, a bold move to challenge the long-standing supremacy of other major web browsers.
Adding further weight to his claims, Hassabis recently explained the sheer scale of progress made by his artificial intelligence systems in the field of protein mapping. Speaking to another well-known tech leader, he remarked:
“So we did a billion years of PhD time in one year. That used to take a PhD student, their entire PhD, as a rule of thumb, to discover one protein structure. So, four or five years, and there’s two hundred million proteins known to science, and we folded them all in one year. And if we know the function, then we can understand what goes wrong in disease. And we can design drugs and molecules that will bind to the right part of the surface of the protein, if you know this structure. So it’s a fascinating problem.”
With artificial intelligence mapping the building blocks of life at lightning speed, the dream of healing the world seems closer than ever before, not just as science fiction, but as an unfolding reality shaped by tireless minds.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
